Curre nt Co mplia nc e I ssue s in Pha rma c y Pra c tic e ME L - - PDF document

10/8/2019 1

Curre nt Co mplia nc e I ssue s in Pha rma c y Pra c tic e

ME L I SSA RE I CHE RT , PHARM.D. OK L AHOMA ST AT E BOARD OF PHARMACY, PHARMACI ST COMPL I ANCE OF F ICE R

F ina nc ia l Disc lo sure a nd Re so lutio n

Unde r g uide line s e sta b lishe d b y the Ac c re dita tio n Co unc il fo r Pha rma c y E duc a tio n (ACPE ), disc lo sure must b e ma de re g a rding fina nc ia l re la tio nships with c o mme rc ia l inte re sts within the la st 12 mo nths.

 I

ha ve no re le va nt fina nc ia l re la tio nships o r a ffilia tio ns with c o mme rc ia l inte re sts to disc lo se .

10/8/2019 2

L e a rning Ob je c tive s

 At the c o mple tio n o f this a c tivity, pha rma c ists will b e

a b le to :

 Re c o g nize c o mmo n c o mplia nc e issue s prio r to a n

Okla ho ma Sta te Bo a rd o f Pha rma c y inspe c tio n.

 E

xpla in the c o rre la tio n b e twe e n pra c tic e site c o mplia nc e a nd pa tie nt sa fe ty.

Pre -Asse ssme nt Que stio n 1

 Wha t drug ma y a no n-Okla ho ma lic e nse d o ut-o f-sta te

physic ia n a ssista nt pre sc rib e ?

 A. T

ra ma do l

 B. Alpra zo la m  C. Pro pra no lo l  D. Ac e ta mino phe n with Co de ine

10/8/2019 3

Pre -Asse ssme nt Que stio n 2

 Ho w o fte n ma y a pa tie nt re q ue st a print o ut o f the ir

PMP re po rt fro m the pha rma c ist?

 A. Annua lly  B. Se mi-a nnua lly  C. Ne ve r  D. One -time o nly

Pre -Asse ssme nt Que stio n 3

 Whe n must a CDS inve nto ry b e ta ke n?  A. Cha ng e o f lo c a tio n  B. Cha ng e o f pha rma c y na me  C. Bi-a nnua lly  D. Cha ng e o f o wne rship

10/8/2019 4

Pre -Asse ssme nt Que stio n 4

 Wha t is the missio n o f the Okla ho ma Bo a rd o f

Pha rma c y?

 A. Pro te c t pha rma c ists  B. Pro te c t physic ia ns  C. Pro te c t c itize ns o f Okla ho ma  D. Pro te c t pha rma c y te c hnic ia ns

Na tio na l Drug Co de (NDC)

 T

he NDC dispe nse d to the pa tie nt sho uld ma tc h the NDC b ille d to insura nc e .

 F

ra udule nt b illing

 I

nsura nc e a udits

10/8/2019 5

T e mpe ra ture L

• g s

 Re frig e ra to r a nd fre e ze r  I

mmuniza tio ns

 Othe r te mpe ra ture se nsitive me dic a tio ns  T

wic e da ily

 Pro pe r te mpe ra ture ra ng e s  Re c o rd e xc ursio ns  E

le c tro nic lo g g ing

Out o f Sta te Mid-L e ve l Pra c titio ne rs

 No n-CDS a llo we d  CDS unc ha ng e d-Okla ho ma lic e nse re q uire d fo r b o th

mid-le ve l pra c titio ne r a nd supe rvising physic ia n

10/8/2019 6

Pha rma c y T e c hnic ia ns

 Must ha ve pe rmit sig ne d b y c urre nt e mplo ye r  Must ha ve initia l tra ining a nd a nnua l tra ining  Bo a rd o f Pha rma c y te c hnic ia n e xa m  I

f tra ining o nline , must print o r ha ve a b ility o n inspe c tio n to lo g in to a ll te c hnic ia n pro file s

 T

e c hnic ia n tra ining do c ume nts o n Bo a rd o f Pha rma c y we b site

Offic e Use Co mpo unds

 No lo ng e r a llo we d fo r re ta il pha rma c ie s b y F

DA

10/8/2019 7

CDS I nvo ic e s

 Ve rify q ua ntity  Da te

DE A Numb e rs fo r Physic ia ns

 Multiple fo r e a c h sta te he / she pra c tic e s  Pha rma c ists must ve rify the a ppro pria te DE

A is use d

 DE

A fine s

10/8/2019 8

CBD

 Do yo u ha ve the Ce rtific a te o f Ana lysis?

HB 2931

 All CDS Rxs must b e e le c tro nic b y Ja n 1, 2020  T

he re a re e xc e ptio ns

10/8/2019 9

PMP

 Ca nno t b e g ive n to the pa tie nt  Ca nno t b e use d fo r yo ur o wn pe rso na l inve stig a tive

purpo se s

Re turn-to -Sto c k Bo ttle s

 Must ha ve a drug e xpira tio n da te  One ye a r o r le ss pe r USP

10/8/2019 10

T he ft

 Bo a rd must b e no tifie d o f a ny the ft  DE

A 106

 OBNDD  Administra tio n  Othe r Bo a rds  No tific a tio n re q uire d re g a rdle ss o f c a use  I

f yo u suspe c t so me thing , a lwa ys re po rt it

HB 2039

 Ma inte na nc e me dic a tio ns  Re fills must b e a utho rize d b y pre sc rib e r  Ma y dispe nse up to 90 da y supply  Only o n no n-CDS  Use pro fe ssio na l judg me nt

10/8/2019 11

No n-CDS invo ic e s

 Ma y b e sto re d e le c tro nic a lly  CDS-still must ha ve pa pe r c o py due to c he c k-in

pro c e sse s

I nspe c tio n Re po rts

 K

e e p until ne xt Bo a rd inspe c tio n

 Must a ddre ss a ll c o rre c tio ns ma de imme dia te ly  Sa mple s o n o ur we b site

10/8/2019 12

F lo a ting Pha rma c ists

 Pha rma c ist lic e nse  I

mmuniza tio n c e rtific a te

 CPR

USP 800

 De c e mb e r 2019  Bo a rd o f Pha rma c y rule s will no t g o into e ffe c t this ye a r

10/8/2019 13

I de ntific a tio n Re q uire me nts

 T

e c hs/ c le rks must we a r a n ide ntific a tio n b a dg e sta ting the ir po sitio n

 I

f wo rk multiple po sitio ns, must ha ve multiple ide ntific a tio n b a dg e s

 Must a lso ide ntify the mse lve s o n the pho ne

CDS I nve nto ry

 Must ha ve c o py o f a nnua l inve nto ry in pha rma c y fo r

inspe c tio n

 DE

A c o py

 I

f PI C c ha ng e , c ha ng e o f o wne r, o r c lo sing

10/8/2019 14

Bo a rd o f Pha rma c y We b site

 Anno unc e me nts  Ne wsle tte rs  F

AQs

 Additio na l Re so urc e s

Missio n

 Pro te c t the he a lth, sa fe ty, a nd we lfa re o f the c itize ns o f

Okla ho ma

 Sa fe ty  Dive rsio n  Co mmitte e s  L

e t yo ur vo ic e b e he a rd!

10/8/2019 15

Po st-Asse ssme nt Que stio n 1

 Wha t drug ma y a no n-Okla ho ma lic e nse d o ut-o f-sta te

physic ia n a ssista nt pre sc rib e ?

 A. T

ra ma do l

 B. Alpra zo la m  C. Pro pra no lo l  D. Ac e ta mino phe n with Co de ine

Po st-Asse ssme nt Que stio n 2

 Ho w o fte n ma y a pa tie nt re q ue st a print o ut o f the ir

PMP re po rt fro m the pha rma c ist?

 A. Annua lly  B. Se mi-a nnua lly  C. Ne ve r  D. One -time o nly

10/8/2019 16

Po st-Asse ssme nt Que stio n 3

 Whe n must a CDS inve nto ry b e ta ke n?  A. Cha ng e o f lo c a tio n  B. Cha ng e o f pha rma c y na me  C. Bi-a nnua lly  D. Cha ng e o f o wne rship

Po st-Asse ssme nt Que stio n 4

 Wha t is the missio n o f the Okla ho ma Bo a rd o f

Pha rma c y?

 A. Pro te c t pha rma c ists  B. Pro te c t physic ia ns  C. Pro te c t c itize ns o f Okla ho ma  D. Pro te c t pha rma c y te c hnic ia ns

10/8/2019 17

I n Summa ry…

 Ple a se re a d ne wsle tte rs a nd a nno unc e me nts to sta y

up-to -da te with c urre nt c o mplia nc e issue s.

 Ne ve r he sita te to c a ll the Bo a rd o f Pha rma c y o ffic e ,

a nd a sk to spe a k to a c o mplia nc e o ffic e r.

 Re vie w sa mple inspe c tio n fo rms to e nsure c o mplia nc e

prio r to yo ur Bo a rd o f Pha rma c y inspe c tio n.

 Alwa ys ma ke a ll c o rre c tio ns re q uire d.  Be pre pa re d, no t sc a re d!

Que stio ns?

 Me lissa Re ic he rt, Pha rma c ist Co mplia nc e Offic e r  mre ic he rt@ pha rma c y.o k.g o v  918-671-9025 (c e ll)

10/8/2019 18

Curre nt Co mplia nc e I ssue s in Pha rma c y Pra c tic e

ME L I SSA RE I CHE RT , PHARM.D. OK L AHOMA ST AT E BOARD OF PHARMACY, PHARMACI ST COMPL I ANCE OF F ICE R